#None #Gross Law Firm #securities lawsuit #Medpace Holdings

Medpace Holdings, Inc.: What Investors Need to Know About the Class Action Lawsuit

Medpace Holdings, Inc. (NASDAQ: MEDP) is currently facing scrutiny as shareholders assert their rights in a potential class action lawsuit. The Gross Law Firm has issued an alert aiming to inform all investors who purchased shares of Medpace during the identified class period from April 22, 2025, to February 9, 2026. Investors are strongly encouraged to reach out and gather more information on how to potentially lead the class action efforts.

Background of the Allegations

The allegations arise from claims that Medpace's management purportedly made misleading statements to investors. According to the formal complaint, the company's executives touted its operational performance with seemingly glowing reports while simultaneously concealing significant adverse facts about the actual performance metrics. This included overstating the cancellation rates of its backlog—misleading investors into believing that cancellations were not indicative of any potential business weakness.

On February 9, 2026, Medpace reported a concerning fourth-quarter book-to-bill ratio of 1.04, which was notably below the company's prior guidance of 1.15. This announcement provoked a severe market response, leading to a dramatic drop in the company's stock price, falling over 15% from $530.35 to $446.05 per share in just one trading day, raising serious questions about the company's statements and practices.

Importance of Registering for Class Action

It’s crucial for shareholders of Medpace to register for the class action lawsuit if they were affected by the stock price decline during the stated period. The Gross Law Firm has indicated that interested parties can seek lead plaintiff status, but participation as a lead plaintiff is not mandatory for sharing in any recoveries from the case. By registering, investors can benefit from a dedicated portfolio tracking service that keeps them informed about the lawsuit's progress.

The deadline to register for consideration as a lead plaintiff is June 8, 2026. Investors should not miss this opportunity to stand against potential corporate misconduct and protect their investment interests. The registration is devoid of any cost, allowing all affected investors to participate without financial obligation.

The Role of The Gross Law Firm

The Gross Law Firm stands dedicated to advocating for investor rights across various sectors. As a nationally recognized law firm, it has established itself in the realm of class action lawsuits, focusing on cases where investors face deception or misinformation from publicly traded companies.

The firm is committed to pursuing justice for investors and ensuring that companies follow ethical and responsible business practices. Their mission includes signaling the importance of accountability in the corporate world, thereby contributing to fairer market conditions for all.

For shareholders who wish to participate in this process or seek more information, contacting The Gross Law Firm is the first step. The firm has provided a link for shareholders to submit their information and join the class action suit. This initiative aims to bring together affected investors and provide them with an opportunity for recovery.

Contact Information

Those wishing to register can find resources on The Gross Law Firm's website. Their contact details are as follows:

• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Email: [[email protected]]
• - Phone: (646) 453-8903

This could be a critical time for Medpace investors, and taking action could make a significant difference in financial recovery efforts amidst corporate transitions and market volatility. Stakeholders should act swiftly as opportunities to join the lawsuit may close soon, and their involvement could be instrumental in addressing the issues at hand.